Ava Schleif has lived with severe food allergies since birth, requiring constant vigilance and preparation for everyday ...

If your immune system overreacts to pollen or other allergens, a diet rich in compounds that boost immune health and reduce ...

Dining plans on campus are meant to accommodate a wide range of needs for students at Ohio State, and this includes students who have a variety of allergies. Here is what students need to know to ...

New biologics, precision diagnostics, and AI are reshaping care for rare allergies — from eosinophilic esophagitis to drug ...

Lactose intolerance is caused by a lack of the enzyme lactase. Milk protein intolerance involves an immune response to ...

There are many reasons to criticize Health Secretary Robert F. Kennedy Jr.’s catastrophic health policies, but he might get credit for one thing: He has spawned a real movement away from ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A millennial woman who thought the discomfort she was feeling in her stomach could be an allergy or gluten intolerance ...

The latest FDA expert panel gave Commissioner Marty Makary, MD, MPH, a chance to sound off on issues close to his heart, but ultimately proved to be a strong science-based forum with some of the world ...

A novel study of a large inpatient cohort found notable disparities across patients diagnosed with eosinophilic esophagitis (EoE) with comorbid food allergies. Ultimately, it was White male teens and ...

Drugmaker GSK said it agreed to acquire Californian biopharmaceutical company RAPT Therapeutics for around $2.2 billion, a move set to bolster its respiratory, immunology and inflammation portfolio.

GSK is paying $2.2 billion to buy Rapt Therapeutics and its anti-immunoglobulin E (IgE) antibody to protect against food allergy reactions. Rapt only licensed the therapy, called ozureprubart, from ...